ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

IDD Innate Pharma

2.13
0.075 (3.65%)
22 Jul 2024 - Closed
Realtime Data
Share Name Share Symbol Market Type
Innate Pharma TG:IDD Tradegate Ordinary Share
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.075 3.65% 2.13 2.13 2.17 2.06 2.06 2.06 20 22:50:06

Additional Listing

28/10/2003 10:59am

UK Regulatory


RNS Number:3769R
ID Data PLC
28 October 2003

                    ID Data plc ("ID Data" or the "Company")


                               Additional Listing



The Company announces that 1,000,000 new Ordinary Shares of 1p each (the 'New
Ordinary Shares') have been issued and allotted following a conversion of
Secured Convertible Loan Notes.



Application has been made for the New Ordinary Shares to be admitted to trading
on AIM, and admission is expected to become effective at 8a.m. on 3 November
2003.




For further information, please contact:
ID Data plc
Peter Cox                                             Tel: +44 (0) 1536 207000
enquiries@id-data.co.uk

Durlacher Limited
Anthony Schia                                         Tel: +44 (20) 7459 5745





Notes to Editors:



ID Data plc ("ID Data") is the world's seventh-largest supplier of
secure-transaction systems and smart-card services to the international
telephony, banking, retail, and secure-access sectors. The Company's strategy,
to move from commodity products to value-added services and solutions, has
created a solid platform on which to build further growth. The Company's clients
include Vodafone, Nectar, Tesco, the Automobile Association, Exxon Mobil and, in
Poland, the Premium Club loyalty card scheme. ID Data has formed agreements with
major global corporations to facilitate rapid market development including
partnerships with Toshiba and Toppan. The Company has delivered in excess of 10
million chip cards to the banking market in the UK. The Company was founded in
1988 and was listed on the AIM market of the London Stock Exchange in October
2000.



www.id-data.co.uk


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

LISEAEEPASKDFFE

1 Year Innate Pharma Chart

1 Year Innate Pharma Chart

1 Month Innate Pharma Chart

1 Month Innate Pharma Chart

Your Recent History

Delayed Upgrade Clock